Blockchain-Fueled Company Mateon Report Positive Results For Multiple Covid-19 Drug Candidates

Created by the recent merger of TGF-beta RNA therapeutics developer Oncotelic and PoinTR – a cluster computer vision empowered blockchain company,  a new immuno-oncology company Mateon has been created. Mateon is dedicated to the development of first in class RNA therapeutics and is particularly focussing on the development of OT-101, a TGF-Beta antisense drug candidate […]

Source :

Date : March 25, 2020 at 04:56PM